Abstract
Interleukin-8 (IL-8) is considered as the major polymorphonuclear neutrophils (PMNs) chemoattractant cytokine in lung diseases such as asthma and adult respiratory distress syndrome (ARDS). However, controversial results were obtained regarding the involvement of IL-8 in the pathogenesis of pneumonia. This study examines the role of IL-8 in the recruitment and activation of PMNs in the lung of pneumonia patients. The interesting aspect of this study is that it is a site- specific analysis of the infected and uninfected lungs of the same patient. The level of IL-8 mRNA, protein and myeloperoxidase present in the cells of the bronchioalveolar lavages (BALs) taken from the areas of known pneumonic consolidations on chest X-ray (infected lung) are compared with the BALs obtained from areas of no obvious infiltrate (non-infected lung). The results obtained from the infected and non-infected lungs of pneumonic patients were further compared with that of a control group of non-smoking patients. The level of IL-8 mRNA and protein were determined by RT-PCR and ELISA respectively. There was a significant increase in the level of IL-8 mRNA in the infected lung as compared to its level in the non-infected lung (p < 0.001). In correlation with the increase in mRNA, IL-8 protein concentrations in BAL fluids from the infected lung were 6 fold higher than those taken from the non-infected lung (p < 0.0001). This pattern was also consistent with MPO activity in the BALs (4.5 fold more MPO activity in the infected lung as compared to that of the non-infected lung), indicating that IL-8 is directly implicated in neutrophil accumulation that follows acute respiratory infection. The results of the present study, therefore, indicate the involvement of IL-8 in the pathogenesis of pneumonia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hiemstra PS: Role of neutrophils and mononuclear phagocytes in host defense and inflammation. JIFCC 5: 224–231, 1993
Goldstein IM, Hoffstein S, Gallin JI, Weissmann G: Mechanisms of lysosomal enzyme release from human leukocytes: Microtubule assembly and membrane fusion induced by a component of complement. Proc Natl Acad Sci USA 70: 2916–2920, 1973
Becker EL, Showell HJ, Henson PM, Hsu LS: The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the enzyme release, importance of surfaces and the relation of enzyme release to chemotactic responsiveness. J Immunol 12: 2047–2054, 1974
Zurier RB, Hoffstein S, Weissmann G: Cytochalasin B: Effect of lysosomal enzyme release from human leukocytes. Proc Natl Acad Sci USA 70: 844–848, 1973
Showell HJ, Freer RJ, Zigmond SH, Schiffmann E, Aswankumar S, Corcoran B, Becker EL: The structure activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils. J Exp Med 143: 1154–1169, 1976
Becker EL: Some interrelations of neutrophil chemotaxis, lysosomal enzyme secretion, and phagocytosis as revealed by synthetic peptides. Am J Pathol 85: 385–394, 1976
Bainton DF, Ullyot JL, Farquhar MG: The development of neutrophilic polymorphonuclear leukocytes in human bone marrow: Origin and content of azurophil and specific granules. J Exp Med 134: 907–1000, 1971
Bainton DF: Sequential degranulation of the two types of polymorphonuclear leukocyte granules during phagocytosis of microorganisms. J Cell Biol 58: 249–261, 1973
Kudo C, Yamashita T, Araki A, Terashita M, Watanabe T, Atsumi M, Tamura M, Sendo F: Modulation of in vivo immune response by selective depletion of neutrophils using a monoclonal antibody, RP-3. I. Inhibition by RP-3 treatment of the priming and effector phases of delayed type hypersensitivity to sheep red blood cells in rats. J Immunol 150: 3728–3738, 1993
Lewis RA, Austin KF: The biologically active leukotrienes. J Clin Invest 73: 889–897, 1984
Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene ‘intercrine’ cytokine family. Annu Rev Immunol 9: 617–648, 1991
Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K: The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243: 1464–1466, 1989
Virchow JC, Kroegel C, Walker C, Matthys H: Inflammatory determinants of asthma severity: Mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma. J Allergy Clin Immunol 98: S27–S33, 1996
Chanez P, Enander I, Jones I, Godard P, Bousquet J: Interleukin 8 in bronchoalveolar lavage of asthmatic and chronic bronchitis patients. Int Arch Allergy Immunol 111: 83–88, 1996
Folkard SG, Westwick J, Millar AB: Production of interleukin-8, RANTES and MCP-1 in intrinsic and extrinsic asthmatics. Eur Respir J 10: 2097–2104, 1997
Shute JK: IL-8 is a potent eosinophil chemoattractant. Clin Exp Allergy 24: 203–206, 1994
Nocker RE et al.: Interleukin-8 in airway inflammation in patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 109: 183–191, 1996
Robinson DS et al.: Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326: 298–304, 1992
Sur S, Kita H, Gleich GJ, Chenier TC, Hunt LW: Eosinophil recruitment is associated with IL-5, but not with RANTES, twenty-four hours after allergen challenge. J Allergy Clin Immunol 97: 1272–1278, 1996
Bousquet JP et al.: Eosinophilic inflammation in asthma. N Engl J Med 323:1033–1039, 1990
Chollet-Martins S, Montravers P, Gibert C, Elbim MC, Desmonts JM, Fagon JY, Gougerot-Pocidalo MA: High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun 61: 4553–4559, 1993
Klebanoff SJ: Oxygen metabolism and toxic properties of phagocytes. Ann Intern Med 93: 480–489, 1980
Hurst JK, Barrette WC Jr: Leukocytic oxygen activation and microbicidal oxidative toxins. CRC Crit Rev Biochem Mol Biol 24: 271–328, 1989
Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162: 156–159, 1987
Maniatis T, Fritsch EF, Sambrook J: In: Molecular Cloning. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1982
Khan I, Collins SM: Altered expression of sodium pump isoforms in the inflamed intestine of Trichinella spiralis-infected rats. Am J Physiol 264: G1160–G1168, 1993
Mukaida N, Shiroo M, Matsushima K: Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immunol 143: 1366–1371, 1989
Khan I, Tabb T, Grafield RE, Grover AK: Polymerase chain reaction assay of mRNA using 28s rRNA as internal standard. Neurosci Lett 147: 114–117, 1992
Bradley PP, Priebat DA, Christensen RD, Rothstein G: Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206–209, 1982
Dean TP, Dai Y, Shute JK, Church MK, Warner JO: Interleukin-8 concentrations are eluted in bronchoalveolar lavage, sputum and sera of children with cystic fibrosis. Pediatr Res 34: 159–161, 1993
Grunewald T, Schuler-Maue W, Ruf B: Interleukin-8 and granulocyte colony-stimulating factor in bronchoalveolar lavage fluid and plasma of human immunodeficiency virus infected patients with pneumocystis carinii pneumonia, bacterial pneumonia, or tuberculosis. J Infect Dis 168: 1077–1078, 1993
Shute JK, Vrugt B, Lindley IJD, Holgate ST, Bron A, Aalbers R, Djukanovic R: Free and complexed interleukin-8 in blood and bronchial mucosa in asthma. Am J Respir Crit Care Med 155: 1877–1883, 1997
Schratzberger P, Dunzendorfer S, Reinisch N, Kähler CM, Wiedermann, CJ: Interleukin-8-induced human peripheral blood B-lymphocyte chemotaxis in vitro. Immunol Lett 58: 167–170, 1997
Shute JK: IL-8 is a potent eosinophil chemoattractant. Clin Exp Allergy 24: 203–206, 1994
Taub DD, Anver M, Oppenheim JJ, Longo DL, Murphy WJ: T-lymphocyte recruitment by interleukin-8. IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo. J Clin Invest 97: 1931–1941, 1996
Wang JM, Xu L, Murphy WJ, Taub DD, Chertov O: IL-8-induced Tlymphocyte migration: Direct as well as indirect mechanisms. Methods 10: 135–144, 1996
Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, Weiner-Kronish JP, Sticherling M, Christophers E, Mattay MA: Elevated levels of NAP-1/interleukin-8 are present in the airspace of patients with adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 146: 427–432, 1992
Matsumoto T, Yokoi K, Mukaida N, Harada A, Yamashita J, Watanabe Y, Matsushima K: Pivotal role of interleukin-8 in the acute respiratory distress syndrome and cerebral reperfusion injury. J Leukocyte Biol 62: 581–587, 1997
Mukaida N, Matsumoto T, Yokoi K, Harada A, Matsushima K: Inhibition of neutrophil-mediated acute lung inflammation injury by an antibody against interleukin-8 (IL-8). Inflamm Res 47: S151–S157, 1998
Hopkins H, Stull T, Von Essen SG, Robbins RA, Rennard SI: Neutrophil chemotactic factors in bacterial pneumonia. Chest 95:1021–1027, 1989
Fujimura M et al.: Sensory neuropeptides are not directly involved in bronchial hyperresponsiveness induced by interleukin-8 in guinea-pigs in vivo. Clin Exp Allergy 26: 357–362, 1996
De Sanctis GT, MacLean JA, Qin S, Wolyniec WW, Grasemann H, Yandava CN, Jiao A, Noonan T, Stein-Streilein J, Green FHY, Drazen JM: Interleukin-8 receptor modulates IgE production and B-cell expansion and trafficking in allergen-induced pulmonary inflammation J Clin Invest 4: 507–515, 1999
Kunkel SL, Standiford T, Kasahara K, Strieter M: Interleukin-8 (IL-8): The major neutrophil chemotactic factor in the lung. Exp Lung Res 17: 17–23, 1991
Taub DD, Oppenheim JJ: Chemokines, inflammation and the immune system. Ther Immunol 1: 229–246, 1994
Strieter RM, Kasahara K, Allen RM, Standiford TJ, Rolfe MW, Becker FS, Chensue SW, Kunkel SL: Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol 141: 397–407, 1992
Kita H, Adolphson CR, Gleich GJ: Biology of eosinophils. In: E. Middleton Jr, E.F. Ellis, J.W. Yuninger, C.A. Reed, N.F. Adkinson Jr, W.W. Busse (eds). Allergy-Principles and Practice, vol. 1. Mosby, St. Louis, 1998, pp 242–260.
Stoeckle MY: Post-transcriptional regulation of gro, and IL-8 mRNAs by IL-1. Nucleic Acids Res 19: 917–920, 1991
Booth JL, Metcalf JP: Type-specific induction of interleukin-8 by adenovirus. Am J Respir Cell Mol Biol 21: 521–527, 1999
Sanz MJ, Weg VB, Bolanowski MA, Nourshargh S: IL-1 is a potent inducer of eosinophil accumulation in rat skin: Inhibition of response by a platelet-activating factor antagonist and an anti-human IL-8 antibody. J Immunol 154: 1364–1373, 1995
Faccioli LH, Nourshargh S, Moqbel R, Williams FM, Sehmi R, Kay AB, Williams TJ: The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. Immunology 73: 222–227, 1991
Walker C, Rihs S, Braun RK, Betz S, Bruijnzeel PL: Increased expression of CD11b and functional changes in eosinophils after migration across endothelial cell monolayers. J Immunol 150: 4061–4071, 1993
Berends C, Dijkhuizen B, de Monchy JGR, Gerritsen J, Kauffman HF: Induction of low density and up-regulation of CD11b expression of neutrophils and eosinophils by dextran sedimentation and centrifugation. J Immunol Meth 167: 183–193, 1994
Youssef PP, Mantzioris BX, Roberts-Thomson PJ, Ahern MJ, Smith MD: Effects of ex vivo manipulation on the expression of cell adhesion molecules on neutrophils. J Immunol Meth 186: 217–224, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abul, H., Abul, A., Khan, I. et al. Levels of IL-8 and myeloperoxidase in the lungs of pneumonia patients. Mol Cell Biochem 217, 107–112 (2001). https://doi.org/10.1023/A:1007264411006
Issue Date:
DOI: https://doi.org/10.1023/A:1007264411006